OTC market in Hungary 2015  Development forecasts for 2015-2020
  • Date of issue: October 2015
  • Delivery: Pdf file

OTC market in Hungary 2015

Development forecasts for 2015-2020

This document supplies the historical market data needed to view current market activity, value and forecasts in accurate context. It also covers a broad range of topics that includes product sales, regulation of OTC production, sales and advertising, analysis of trends and the latest on consumer preferences with regard to medicines and dietary supplements available for purchase without a prescription.

 

The report also supplies forecasts for OTC market development during the period 2015-2020.

 

Key report components include…

  • Market news that includes significant events, the latest updates on consumer behaviour with regard to OTC products
  • In-depth analysis of the market impacts of current regulations and proposed changes on OTC sales and growth
  • A large collection of historical and current data and market indicators that cover value, explain structure and describe the activities and performance of major market players.

 

This report describes the products, players and prospects for this market…

  • Discover which OTC products continue to post the highest sales numbers on the Hungarian market
  • Compare the share of OTC sales in Hungary to that of the country’s entire pharmaceutical sector
  • Examine Hungary’s leading manufacturers of OTC products in terms of size, market share, earnings and growth strategies
  • Review the latest value and growth data and detailed forecasts for all segments of the OTC market in Hungary.

 

It offers answers to pressing business questions…

  • How do current market participants view the regulatory environment for OTC production and sales in Hungary?
  • What is the current degree of saturation on this market?
  • What is the current value of the OTC market in Hungary?
  • Which strategies have companies used to grow their businesses on the Hungarian OTC market?
  • What developmental indicators are expected in this market for the remainder of the decade?

 

This publication is an essential aid to the operations of…

  • OTC product wholesalers active in Hungary
  • Manufacturers of OTC products for sale in Hungary
  • Consultants, researchers and academic professionals
  • Businesses selling OTC products online
  • Embassies and government offices.

 

PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. Senior Trade and Investment Adviser, British Embassy in Warsaw
It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner. Business Analyst, Hilti Distribution, Russia
We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis. Senior Trade and Investment Adviser, British Embassy in Warsaw
PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales. Market Analyst, Alpha Cement
PMR provides a good service and is always open to discussion. All reports are well structured & are always on time. Member of the Managment Board, SCA Hygiene Products
As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding. Development Manager, GVA Grimley

  • Methodology
  • Executive summary
    • CE region
    • Hungary
  • Overview of the OTC market in Hunagry
    • Main trends and events on the OTC market
    • OTC market value
      • OTC market by distribution channel
      • OTC market value by product status (drugs vs dietary supplements)
      • Share of OTC products as a proportion of the pharmaceutical market
      • Value of the OTC product market between 2011 and 2020
      • Volume of the OTC drugs market between 2011 and 2014
      • Value of the dietary supplement market
      • OTC product market by therapeutic categories
    • Prices of OTC products
    • Switch from Rx to OTC
    • Bestselling OTC products
    • Advertising
      • Legal framework
      • Spending on OTC advertising
    • Key players
      • OTC drugs
      • Dietary supplements
      • Important events pertaining to companies present on the market
  • Profiles of selected manufacturers on the OTC market in CE
    • Bayer HealthCare
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Berlin-Chemie/Menarini
      • General information
      • Financial results
      • Product portfolio
    • GlaxoSmithKline
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Krka
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Novartis/Sandoz
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Sanofi
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Teva
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Walmark
      • General information
      • Product portfolio
      • Market strategy and OTC sales in CE

Graphs

  • Value (€ bn) and change (%, y-o-y) of the OTC product market in CE, 2011-2020
  • Number of dietary supplements in Hungary of which launch the National Institute for Food and Nutrition Science was notified, 2011-Jul 2015
  • Number of dietary supplements banned in Hungary and change (%), 2005-July 2015
  • Number of items on the list of drugs authorised to be sold at non-pharmacy outlets in Hungary, 2012-2015
  • Share of dietary supplements as a proportion of the total OTC product market in Hungary (%), by value, H1 2014
  • Share of OTC products as a proportion of the Hungarian pharmaceutical market (%), by value, 2014
  • Share of OTC products as a proportion of the pharmacy market in Hungary (%), 2007-2014
  • Change in value of Hungarian pharmacy market (%), by category, 2011-2014
  • Value (HUF bn) and change (%, y-o-y) of the OTC product market in Hungary, 2011-2020
  • Volume of the OTC drugs market in Hungary (million packets) and change (%), 2011-2014
  • Value (HUF bn) and change (%, y-o-y) of the dietary supplement pharmacy market in Hungary, 2005-2014
  • Average pharmacy drug prices in Hungary (HUF), 2014
  • Number of changes in status from prescription drug to OTC medication in Hungary, 2013-August 2015
  • Spending on advertising of OTC products in Hungary (HUF bn) and change (%), 2009-H1 2015
  • Top categories of OTC products in terms of TV advertising spending in Hungary (%), by value, 2014
  • OTC categories most advertised on TV in Hungary, by number of advertisements, 2014
  • Top categories of OTC products in terms of TV advertising spending in Hungary (%), by value, H1 2015
  • OTC categories most advertised on TV in Hungary, by number of advertisements, H1 2015
  • Krka Group employee breakdown, by regions, 2014
  • Krka global revenues and net profit (€ m), 2005-H1 2015
  • Share of new products as a proportion of Krka’s total sales value (%), 2009-2014
  • Krka global revenues from OTC products (€ m) and y-o-y change (%), 2011-H1 2015
  • Share of Krka sales as a proportion of the total global market, by region (%), 2014-H1 2015
  • Krka sales in CE countries analysed (€ m), 2013-Q1 2015
  • Krka global OTC sales (%), by product groups, 2014
  • Number of Walmark employees in CE countries analysed, 2014
  • Walmark sales revenues in Hungary (€ m) and change (%, y-o-y), 2010-2014

Tables

  • Main trends and events, and their effect on the OTC market in Hungary, 2014-2015
  • OTC drugs introduced to non-pharmacy sale in Hungary, 2013-May 2015
  • Frequency of purchase of medicines, vitamins and dietary supplements via the internet in Hungary (%), 2013-2015
  • Anticipated trends and events and their effect on the OTC market in Hungary, 2015-2020
  • OTC drugs market in Hungary, by main product categories (€ m), 2013-2020
  • Average price of dietary supplements in Hungary in comparison with OTC products (HUF), January 2008 and January 2014
  • Rx-to-OTC switches in Hungary, 2013-August 2015
  • Bestselling OTC drugs in Hungary, by value (HUF bn), 2014
  • Advertising spending of pharmaceutical manufacturers in Hungary (HUF bn) and change (%), by channel, 2012-2014 and H1 2015
  • Spending on OTC products advertising in Hungary in comparison with total market (%), by channel, 2014
  • Spending on OTC products advertising in Hungary in comparison with total market (%), by channel, H1 2015
  • Leading advertisers of OTC brands in Hungary, by amount spent (HUF bn), 2014
  • Leading advertisers of OTC brands in Hungary, by amount spent (HUF bn), H1 2015
  • Leading OTC products in Hungary by amount spent on advertising (HUF bn), 2014
  • Leading OTC products in Hungary by amount spent on advertising (HUF bn), H1 2015
  • Top 10 manufacturers of OTCs in Hungary, by value, 2014
  • Top 10 manufacturers of dietary supplements in Hungary, by value (HUF), July 2013-June 2014
  • General information pertaining to Bayer HealthCare, 2015
  • Sales of individual Bayer companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Bayer product portfolio, 2015
  • General information pertaining to Berlin-Chemie/Menarini, 2015
  • Sales of individual Berlin-Chemie/Menarini companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Berlin-Chemie/Menarini product portfolio, 2015
  • General information pertaining to GlaxoSmithKline, 2015
  • Sales of individual GSK companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to GSK product portfolio, 2015
  • General information pertaining to Krka, 2015
  • Ownership structure of Krka (%), 2015
  • Structure of Krka in CE countries analysed, 2015
  • Krka's sales of OTC products in selected CE countries (€ m), 2011-2014
  • Krka sales breakdown, by product or category of service (€ m), and change (y-o-y, %), 2014
  • Krka global sales (€ m), by region, 2012-H1 2015
  • General information pertaining to Krka product portfolio in CE countries analysed, 2015
  • Most substantial increases in sales value of Krka’s OTC products (%), H1 2015
  • General information pertaining to sales of Krka’s OTC products in Hungary, 2015
  • General information pertaining to Novartis/Sandoz, 2015
  • Sales of individual Novartis/Sandoz companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Novartis/Sandoz product portfolio, 2015
  • General information pertaining to Sanofi, 2015
  • Sales of individual Sanofi companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Sanofi product portfolio, 2015
  • General information pertaining to Teva, 2015
  • Sales of individual Teva companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Teva product portfolio, 2015
  • General information pertaining to Walmark, 2015
  • Ownership structure of Walmark (%), 2014
  • Structure of Walmark in CE countries analysed, 2015
  • General information pertaining to Walmark product portfolio, 2014
  • General information pertaining to sales of Walmark OTC products in Hungary, October 2015